Ballicules.com

Hydrocodone ER (q12h)

ZOHYDRO ER

What it isFirst single-agent hydrocodone (ZOHYDRO ER, 2013) — q12h ER capsule with no acetaminophen, freeing dosing from APAP hepatotoxicity limits.

Why this oneSame molecule and receptor pharmacology as the parent card — the formulation (and its label) is the difference.

What limits itClass warnings of the parent molecule apply unchanged.

FDA-approved for

FDA label

BOXED WARNING Addiction, abuse, and misuse; life-threatening respiratory depression; accidental ingestion; neonatal opioid withdrawal syndrome; interaction with alcohol; CYP3A4 interaction
FDA dosingPopulationStartTargetMax
Pain severe enough to require daily, around-the-clock, long-term opioid treatment when alternatives are inadequateAdults10 mg q12h (opioid-naïve/non-tolerant)IndividualizedIndividualized (>80 mg/day only in opioid-tolerant)

Titration Adjust in increments of 10 mg q12h no more often than every 3–7 days

Renal Initiate at a low dose; monitor for respiratory depression and sedation

Hepatic Mild–moderate: no starting-dose adjustment; severe: start 10 mg q12h

Dose every 12 hours; 50 mg capsule, single dose >40 mg, or total daily dose >80 mg only for opioid-tolerant patients

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Prolonged use during pregnancy can cause neonatal opioid withdrawal syndrome

Lactation Not recommended

⚠ BOXED WARNINGS

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Hydrocodone ER (q12h) ballicule

Hydrocodone ER (q12h) ballicule: receptor binding, kinetics and half-life diagram

Open Hydrocodone ER (q12h) in the interactive console ↗

Memory aids: mascots and interaction avatars

Hydrocodone ER (q12h) VICODIN / NORCO mascot mnemonic cartoon
“Viking Hydrant code”
Viking for Vicodin (combo with acetaminophen)
Hydrocodone ER (q12h) CYP2D6 substrate avatar
CYP2D6 substrate
Hydrocodone ER (q12h) CYP3A4 substrate avatar
CYP3A4 substrate

Open Hydrocodone ER (q12h) in the interactive console ↗